These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1453 related items for PubMed ID: 18583464

  • 21. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
    Meyer C, McGrath BP, Teede HJ.
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
    [Abstract] [Full Text] [Related]

  • 22. Diet-Induced Weight Loss Reduces DNA Damage and Cardiometabolic Risk Factors in Overweight/Obese Women with Polycystic Ovary Syndrome.
    Soares NP, Santos AC, Costa EC, Azevedo GD, Damasceno DC, Fayh AP, Lemos TM.
    Ann Nutr Metab; 2016 Oct; 68(3):220-7. PubMed ID: 27073909
    [Abstract] [Full Text] [Related]

  • 23. A Randomized Trial of the Efficacy of Three Weight Loss Diet Interventions in Overweight/Obese with Polycystic Ovary Syndrome.
    Dou P, Zhang TT, Xu Y, Xue Q, Zhang Y, Shang J, Yang XL.
    Endocr Metab Immune Disord Drug Targets; 2024 Oct; 24(14):1686-1697. PubMed ID: 38988067
    [Abstract] [Full Text] [Related]

  • 24. A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome.
    Stamets K, Taylor DS, Kunselman A, Demers LM, Pelkman CL, Legro RS.
    Fertil Steril; 2004 Mar; 81(3):630-7. PubMed ID: 15037413
    [Abstract] [Full Text] [Related]

  • 25. Fat loss depends on energy deficit only, independently of the method for weight loss.
    Strasser B, Spreitzer A, Haber P.
    Ann Nutr Metab; 2007 Mar; 51(5):428-32. PubMed ID: 18025815
    [Abstract] [Full Text] [Related]

  • 26. Effect of Lifestyle Intervention on Cardiometabolic Risk Factors in Overweight and Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
    Khatlani K, Njike V, Costales VC.
    Metab Syndr Relat Disord; 2019 Dec; 17(10):473-485. PubMed ID: 31513475
    [Abstract] [Full Text] [Related]

  • 27. Six weeks of structured exercise training and hypocaloric diet increases the probability of ovulation after clomiphene citrate in overweight and obese patients with polycystic ovary syndrome: a randomized controlled trial.
    Palomba S, Falbo A, Giallauria F, Russo T, Rocca M, Tolino A, Zullo F, Orio F.
    Hum Reprod; 2010 Nov; 25(11):2783-91. PubMed ID: 20858697
    [Abstract] [Full Text] [Related]

  • 28. [Diet, metformin and inositol in overweight and obese women with polycystic ovary syndrome: effects on body composition].
    Le Donne M, Alibrandi A, Giarrusso R, Lo Monaco I, Muraca U.
    Minerva Ginecol; 2012 Feb; 64(1):23-9. PubMed ID: 22334228
    [Abstract] [Full Text] [Related]

  • 29. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome.
    Thomson RL, Buckley JD, Moran LJ, Noakes M, Clifton PM, Norman RJ, Brinkworth GD.
    BJOG; 2009 Aug; 116(9):1242-50. PubMed ID: 19438498
    [Abstract] [Full Text] [Related]

  • 30. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
    Ujvari D, Hulchiy M, Calaby A, Nybacka Å, Byström B, Hirschberg AL.
    Hum Reprod; 2014 Jul; 29(7):1526-35. PubMed ID: 24842895
    [Abstract] [Full Text] [Related]

  • 31. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
    Toscani MK, Mario FM, Radavelli-Bagatini S, Spritzer PM.
    Nutr Res; 2011 Feb; 31(2):97-103. PubMed ID: 21419313
    [Abstract] [Full Text] [Related]

  • 32. Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study.
    Gambineri A, Patton L, Vaccina A, Cacciari M, Morselli-Labate AM, Cavazza C, Pagotto U, Pasquali R.
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3970-80. PubMed ID: 16868063
    [Abstract] [Full Text] [Related]

  • 33. The use of anti-mullerian hormone in predicting menstrual response after weight loss in overweight women with polycystic ovary syndrome.
    Moran LJ, Noakes M, Clifton PM, Norman RJ.
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3796-802. PubMed ID: 17652213
    [Abstract] [Full Text] [Related]

  • 34. Pigment epithelium-derived factor, insulin sensitivity, and adiposity in polycystic ovary syndrome: impact of exercise training.
    Joham AE, Teede HJ, Hutchison SK, Stepto NK, Harrison CL, Strauss BJ, Paul E, Watt MJ.
    Obesity (Silver Spring); 2012 Dec; 20(12):2390-6. PubMed ID: 22641183
    [Abstract] [Full Text] [Related]

  • 35. Effects of exercise and group counselling on body composition and VO2max in overweight women with polycystic ovary syndrome.
    Roessler KK, Birkebaek C, Ravn P, Andersen MS, Glintborg D.
    Acta Obstet Gynecol Scand; 2013 Mar; 92(3):272-7. PubMed ID: 23237575
    [Abstract] [Full Text] [Related]

  • 36. Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome.
    Paradisi G, Steinberg HO, Shepard MK, Hook G, Baron AD.
    J Clin Endocrinol Metab; 2003 Feb; 88(2):576-80. PubMed ID: 12574183
    [Abstract] [Full Text] [Related]

  • 37. Sibutramine administration decreases serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome.
    Vosnakis C, Georgopoulos NA, Armeni AK, Papadakis E, Roupas ND, Katsikis I, Panidis D.
    Eur J Obstet Gynecol Reprod Biol; 2012 Aug; 163(2):185-9. PubMed ID: 22579228
    [Abstract] [Full Text] [Related]

  • 38. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women.
    Engelson ES, Agin D, Kenya S, Werber-Zion G, Luty B, Albu JB, Kotler DP.
    Metabolism; 2006 Oct; 55(10):1327-36. PubMed ID: 16979403
    [Abstract] [Full Text] [Related]

  • 39. High Intensity Interval- vs Moderate Intensity- Training for Improving Cardiometabolic Health in Overweight or Obese Males: A Randomized Controlled Trial.
    Fisher G, Brown AW, Bohan Brown MM, Alcorn A, Noles C, Winwood L, Resuehr H, George B, Jeansonne MM, Allison DB.
    PLoS One; 2015 Oct; 10(10):e0138853. PubMed ID: 26489022
    [Abstract] [Full Text] [Related]

  • 40. Exercise decreases anti-müllerian hormone in anovulatory overweight women with polycystic ovary syndrome: a pilot study.
    Moran LJ, Harrison CL, Hutchison SK, Stepto NK, Strauss BJ, Teede HJ.
    Horm Metab Res; 2011 Dec; 43(13):977-9. PubMed ID: 21989557
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 73.